Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Research & Development Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Research & Development
-kr179m
CAGR 3-Years
-44%
CAGR 5-Years
-18%
CAGR 10-Years
-18%
AddLife AB
STO:ALIF B
Research & Development
-kr97m
CAGR 3-Years
-60%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biotage AB's Research & Development?
Research & Development
-179m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Research & Development amounts to -179m SEK.

What is Biotage AB's Research & Development growth rate?
Research & Development CAGR 10Y
-18%

Over the last year, the Research & Development growth was -28%. The average annual Research & Development growth rates for Biotage AB have been -44% over the past three years , -18% over the past five years , and -18% over the past ten years .

Back to Top